Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...

Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Merck and Intel have launched a collaborative academic research initiative in Europe, bringing together eleven institutions ...

The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...

In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...

Global Inhalable Drugs market size is expected to reach US$ 56.68 Bn by 2030, from US$ 34.86 Bn in 2023, exhibiting a CAGR of 7.2% during the forecast period. Mr. Shah Coherent Market Insights Pvt.

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Intel Corporation, one of the world's largest semiconductor designers and manufacturers, have begun the implementation of ...